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We think of pain as a symptom. But in . . . patients [with chronic pain], the pain is the
disease.
—Clifford J. Woolf, director of the F.M. Kirby Neurobiology Center at
Boston Children’s Hospital and neurology professor at Harvard Medical
School1

INTRODUCTION
Shortly before receiving yet another lidocaine needle in the back of his neck, Staff Sergeant
Josh Kisner, an Army veteran who suffers from severe headaches and chronic neck pain,
confessed:
I don’t know why it is starting up again. It had calmed down to a tolerable level. It’s the
stupidest things like reaching into the closet to grab a shirt. For a while, I just lived on
1

Lenny Bernstein, For some with chronic pain, the problem is not in their backs or knees but their brains, WASH.
POST (Sept. 23, 2019, 7:26 PM), https://www.washingtonpost.com/national/health-science/for-some-with-chronicpain-the-problem-is-not-in-their-backs-or-knees-but-their-brains/2019/09/23/80538660-5d5c-11e9-842d7d3ed7eb3957_story.html. See also OWEN D. JONES ET AL., LAW AND NEUROSCIENCE 344 (2014).
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Percocets. It was the only way to do it. That’s why I hate that drug and if they give it to
me after surgery, I am going to beg for something else.2
This was just another day “along recovery” for Kisner, who avoided medical evacuation despite
experiencing symptoms of traumatic brain injury (“TBI”), while deployed in Baqubah, Iraq in
2007.3 Fellow Army veteran Justin Springer made Kisner’s story accessible to the public through
his documentary, Along Recovery, which bravely and respectfully follows four wounded soldiers
whose lives changed dramatically after returning from Iraq and Afghanistan and captures their
treatment experiences at Brooke Army Medical Center in San Antonio, Texas.4 Springer describes
the health conditions faced by soldiers returning from overseas combat deployments: severe
headaches, chronic pain, sleeplessness, depression, and memory and concentration issues, among
others.5 It is frustrating because “you can have all these problems but there’s no real way to
pinpoint why you are having them.”6 When doctors give soldiers an MRI, “it almost always comes
back negative and they can’t really see why you are having any problems.”7
As Sean Hollins, a soldier suffering from a TBI explained, he would contemplate
withholding how he felt from the hospital because “they say[,] hey[,] let’s give you some more
medication,”8 and he is “not a big fan of medications.”9 The initial instinct of doctors to prescribe
to soldiers opioids as part of their treatment plan, without more, leads to opioid misuse and

2

Along Recovery, (Gravitas Ventures May 20, 2012), https://www.amazon.com/Along-Recovery-JustinSpringer/dp/B00GDF77AM. 49:11-49:40.
3
Along Recovery, supra note 2, at 17:10-17:16.
4
Id. at 17:10-17:16.
5
Id. at 20:28-20:56.
6
Id. at 20:28-20:56.
7
Id. at 20:28-20:56.
8
Id. at 28:00-28:32.
9
Id. at 30:50-31:02.
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addiction.10 This sad reality highlights how the treatment process affects people suffering from
chronic pain and comorbid conditions.11

Witnessing how these soldiers struggled through

Springer’s eye-opening documentary footage frames the need to re-assess the current treatment
protocols for the disease of chronic pain.
This paper argues that there is a disconnect between our understanding of chronic pain and
the legal infrastructure surrounding treatment of the disease. The healthcare delivery system
currently limits or denies patients access to evidence-based alternatives that demonstrably alleviate
chronic pain. This paper proceeds as follows. Part I provides a brief overview of the addicted brain
and the opioid crisis and explains how these topics connect with chronic pain. Part II examines the
efficacy of evidence-based treatment methods, existing guidelines on chronic pain treatment, and
the importance of integrating alternative treatment methods into a pain patient’s multidisciplinary
treatment plan. It then addresses problems under current law, including the lack of insurance
coverage for evidence-based alternative pain treatments. Part III proposes legal reforms to bridge
these gaps. Specifically, it recommends that the Department of Health and Human Services
(“HHS”) condition state funding for chronic pain—in connection with opioid-related funding—on
state medical boards’ implementation of a mandated 15-week evidence-based alternative treatment
plan in place of opioid therapy or, where medically necessary, in conjunction with prescription

10

See Jennifer D. Oliva, Son of Sam, Service-Connected Entitlements, and Disabled Veteran Prisoners, 25 GEO.
MASON L. REV. 302, 303 n.7 (2018) (citing sources that reference veterans facing addiction, including Andrew Golub
& Alexander S. Bennett, Introduction to the Special Issue: Drugs, Wars, Military Personnel, and Veterans, 48
SUBSTANCE USE & MISUSE 795, 796 (2013)).
11
Josh Roe, One veteran tells the story of his struggles trying to manage chronic pain, ABC NEWS CHANNEL (Sept.
11, 2019), https://newschannel9.com/features/price-of-freedom/one-veteran-tells-the-story-of-his-struggles-tryingto-manage-chronic-pain (describing veteran Scott McConathy struggles because for 12 years doctors gave him 60 mg
of Morphine 3 times per day, lowered to 40 milligrams of hydrocodone, then cut him off).
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opioids. It further contends that HHS ought to require evidence of protocols implementing
individualized plans that integrate any combination of sessions in therapies including, but not
limited to, cognitive behavioral therapy, yoga, acupuncture, and physical therapy. In additional,
federal law should require insurance companies to cover these evidence-based alternatives.
Part IV examines some potential problems that could result from the solutions proposed in
Part III. Those include the additional demands required of doctors and other practitioners treating
patients for pain, namely focusing additional time and resources on these patients, as well as
demands on insurance companies that have thus far failed to provide coverage for alternatives.
Part IV responds to these concerns and the resistance to change in several ways. It argues that: (i)
chronic pain already costs our country because people are suffering and dying from the misuse of
opioids; (ii) this country has spent billions of dollars on this public health crisis already with limited
progress; (iii) the cost of alternative treatments is not measurable without attempting to effectively
implement a program to fill the known gaps in chronic pain treatment; and (iv) these alternatives
are cost- and resource-effective. This paper concludes by reiterating the need for mandatory,
individualized evidence-based alternative treatment plans for chronic pain patients.
I.

BACKGROUND
A. The U.S. Opioid Misuse and Overdose Public Health Crisis: Brain Effects
and Relevant Statistics
The United States is facing a substance use disorder and drug overdose public health

crisis.12 In the United States, over 130 people die each day after overdosing on opioids according

Puja Seth et al., Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–
2016, 67 MORBIDITY & MORTALITY WKLY. REP. 1, 1 (2018).
12
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to the National Institute of Health (“NIH”).13 In 2017, opioid use disorder resulted in 47,600 drugoverdose deaths.14 Advances in neuroscience show the effects of drugs on neural pathways and
differences in brain-wiring between people suffering from opioid use disorder and those that do
not.15 The CDC published opioid prescribing guidelines in 2016, which recommend dosage
limitations and the satisfaction of certain threshold requirements prior to prescription renewal.16
While the guidelines are useful, there was controversy surrounding their implementation17 and
they are insufficient standing alone. Neuroscience research demands a change in our approach to
treating the underlying disease of pain due to its effects on brain circuitry and quality of life. If we
intend to overcome the opioid crisis, it is critical that we reassess our view of the addicted brain,
especially in the context of chronic pain.
B. The connection between chronic pain and opioid use disorder
Chronic pain and opioid use disorder are interrelated. The Institute of Medicine Report on
Pain (“IOM Report”) suggests that 100 million Americans suffer from pain.18 “The medical

13

NATIONAL INSTITUTE ON DRUG ABUSE, Opioid Overdose Crisis, https://www.drugabuse.gov/drugsabuse/opioids/opioid-overdose-crisis (last visited Nov. 21, 2019).
14
See U.S. DEP’T OF HEALTH & HUMAN SERVS., CTRS. FOR DISEASE CONTROL & PREVENTION, Overview of the Drug
Overdose Epidemic: Behind the Numbers, https://www.cdc.gov/drugoverdose/data/ (last visited Nov. 12, 2019).
(citing Lawrence Scholl et al., Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017, 67
MORBIDITY & MORTALITY WKLY. REP. 1419, 1419 (2019)).
15
Alan I. Leshner, Addiction is a Brain Disease, and It Matters, 278 SCIENCE 45, 45 (1997), in OWEN D. JONES ET
AL., LAW AND NEUROSCIENCE 592 (2014).
16
Deborah Dowell et al., CDC Guideline for Prescribing Opioids for Chronic Pain, 65 MORBIDITY & MORTALITY
WKLY. REP. 1, 30 (2016),
https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2F
mmwr%2Fvolumes%2F65%2Frr%2Frr6501e1er.htm.
17
See infra notes 74-76 and accompanying text.
18
Position Statement, American Academy of Pain Medicine, Use of Opioids for the Treatment of Chronic Pain (Mar.
7, 2013), https://painmed.org/about/position-statements/use-of-opioids-for-the-treatment-of-chronic-pain (citing
Institute of Medicine, Committee on Advancing Pain Research, Care and Education, Relieving Pain in America: A
Blueprint for Transforming Prevention, Care, Education, and Research, WASHINGTON (DC): NATIONAL ACADEMIES
PRESS (US) (2011) [hereinafter IOM REPORT]).
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blunder of casually prescribing opioids for acute and chronic pain is partly to blame for the
addiction crisis that has taken more than 400,000 lives over the past 20 years.”19 Many who suffer
from chronic pain are either not receiving adequate treatment or relying on opioids.20 Critically,
the relief from opioids is temporary, so opioids are not effective at managing patients’ pain.21
When the opioids wear off, the pain becomes prevalent.22 This, in turn, causes pain to affect
patients like a debilitating disease, resulting in the patient’s need for more opioids and ongoing
dependency, with limited relief.23 Change is on the horizon, but before this paper discusses current
developments, it provides some background on chronic pain and the legal framework.
C. The law’s understanding of chronic pain and the disconnect reflected by
legal framework
Chronic pain is pain that persists past the end of the injury-related healing process, which
differentiates chronic pain from acute pain.24 Chronic pain generally is pain that lasts more than
three months.25 Pain results from neurological changes, affecting the central nervous system and
peripheral nerves; it does not have to be the product of something else.26 In other words, “you can
have an injury that heals and still have pain [or] you can have no specific injury and have pain . . .

19

See Bernstein, supra note 1, at 1 (observing that casually prescribing opioids plays a role in opioid-related deaths).
Puja Seth et al., supra note 11, at 1.
21
Id. at 1.
22
Id. at 1.
23
Matt Seidholz & Allison Young, Can Cognitive Behavioral Therapy Help Reduce Pain Better Than Opioids?,
EVERYDAY HEALTH (Nov. 21, 2018), https://www.everydayhealth.com/opioids/can-cognitive-behavioral-therapyhelp-reduce-pain-better-than-opioids/.
24
OWEN D. JONES ET AL., LAW AND NEUROSCIENCE 344 (2014).
25
Jennifer L. Murphy et al., Cognitive behavioral therapy for chronic pain among veterans: Therapist manual 11,
U.S.
DEPARTMENT
OF
VETERANS
AFFAIRS,
https://www.va.gov/PAINMANAGEMENT/docs/CBTCP_Therapist_Manual.pdf (last visited Nov. 21, 2019).
26
Amanda C. Pustilnik, Address at the Mass General Hospital Center for Law, Brain & Behavior Public Symposium:
The Pain Brain in Evidence and Policy—Visible Solutions: How Neuroimaging Helps Law Re-Envision Pain (June
30, 2015).
20
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[The pain] is in the brain.” 27 Chronic pain, as experienced by an individual, results from a
combination of physical, psychological, and environmental factors, and thus pain is subjective and
difficult to quantify objectively.28
The law relies on an outdated conceptualization of pain, which affects the evaluation of
pain and legal compensation for it. Carradine v. Barnhart depicts chronic pain and how courts
historically have approached pain.29 Here, Carradine slipped and fell and her pain endured.30 The
court denied her request for disability benefits, finding a lack of “objective evidence” to support
her alleged pain.31 The appellate court reversed, reasoning that back surgery and taking painkillers
were objective measures she took to lessen her pain.32 However, the court went on to point to the
psychosomatic aspect of her pain, by proclaiming that her back was fine, and her complaints show
that the pain is all “in her head.”33 Such reasoning demonstrates the law’s lack of understanding
of pain and its effect on the framework for providing relief for pain patients.34
Law professor Amanda C. Pustilnik pointed out the abovementioned holes in the legal
analysis in Carradine.35 She poignantly noted that “the Social Security Administration said in 1984
that they wanted to reconsider their pain reg[ulations], and we are still in the same place. It might
be easier to reach judges and change the law interstitially through interpretation.”36 This paper

27

Id. at 10:26-10:30 (emphasis added).
Daniel J. Gabler, Conscious Pain and Suffering Is Not a Matter of Degree, 74 MARQ. L. REV. 289, 296 (1991).
29
See Carradine v. Barnhart, 360 F.3d 751 (7th Cir. 2004).
30
Id. at 753.
31
Id. at 751.
32
Id. at 754.
33
Id. at 754.
34
Pustilnik, supra note 25, at 03:15-04:02.
35
Id. at 05:05-08:28.
36
Id. at 50:48-51:38.
28
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argues that it is beyond time to make such changes, but it is important to take a look at the research
on evidence-based alternatives prior to delving into that discussion.
II.

THE EVIDENCE-BASED ALTERNATIVES AND MULTIDISCIPLINARY
TREATMENT PLAN CHRONIC PAIN PATIENTS DESERVE FOR
TREATING THEIR DISEASE
Studies on non-pharmacological alternatives for treatment of chronic pain repeatedly deem

such treatment methods effective.37 This section looks at broad studies and trends and then delves
into specific research that demonstrates the efficacy of cognitive behavioral therapy, physical
therapy, and acupuncture as examples of the need for implementation of evidence-based
alternatives. It then chronicles several recent recommendations to treat pain patients with evidencebased treatment alternatives to opioids, the need for a multidisciplinary patient-centric
individualized treatment plan, problems under current law (including lack of insurance coverage
for evidence-based alternatives), and findings from brain imaging related to chronic pain.
A. Studies on the efficacy of evidence-based alternatives
Studies exploring evidence-based alternatives for treatment of chronic pain demonstrate
the effectiveness of such alternative treatments in improving patient outcomes, with an important
caveat—that certain evidence-based alternatives work better than others for specific chronic pain
conditions.38 One 2007 study explored the effectiveness of chiropractic, meditation, hypnosis,
yoga, biofeedback, and acupuncture in treating chronic pain.39 It suggests that these alternative

37

Luca Scascighini et al., Multidisciplinary treatment for chronic pain: a systematic review of interventions and
outcomes, 47 RHEUMATOLOGY 1, 11 (2008).
38
Andrea C. Skelly et al., Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review, 209
AGENCY FOR HEALTHCARE RESEARCH & QUALITY 1, 40 (2018), https://www.ncbi.nlm.nih.gov/books/NBK519958/.
39
Gabriel Tan et al., Efficacy of selected complementary and alternative medicine interventions for chronic pain, 44
J. REHAB. RESEARCH & DEV. 195, 195 (2007).
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treatment modalities have varying levels of efficacy, and clinicians should become familiar with
these non-pharmacological methods and consider incorporating them into treatment plans.40
Separately, trends became apparent in soldiers, who suffered from injuries in training or in
combat. As a result of injuries, soldiers experienced tremendous pain, compounded by PTSD and
traumatic brain injury, and sadly, they showed little response to the treatment methods health care
practitioners implemented.41 Due to a high rate of psychological illnesses, suicide, drug and
alcohol addiction, the Army Surgeon General’s Pain Management Task Force (“PMTF”) came
about in 2009 to create a “comprehensive pain management strategy that was holistic, multidisciplinary and multi-modal in its approach.”42 The PMTF published a formal report in 2010,
which included over 100 recommendations for practice, education, research, and organizational
changes at all levels.43 The abovementioned IOM Report followed.44 Both reports recommended
and endorsed evidence-based alternatives for pain patients and a patient-centered, multimodal
treatment plan.45 The next section examines the efficacy of specific evidence-based alternatives to
prescription opioids—cognitive behavioral therapy, physical therapy, and acupuncture.
1. Efficacy of Cognitive Behavioral Therapy for chronic pain
Cognitive Behavioral Therapy (“CBT”) is a form of psychotherapy focused on present
circumstances and emotions and uprooting negativity.46 In the context of chronic pain, successful

40

Id. at 208.
Eric Schoomaker & Chester Buckenmaier, Call to Action: ‘If Not Now, When? If Not You, Who?’, 15 PAIN MEDICINE
S4, S5 (2014).
42
Id. at S5.
43
Id. at S5.
44
See Schoomaker & Buckenmaier, supra note 40, at S5; IOM REPORT, supra note 17, at 93.
45
Id. at S5.
46
David A. Hanscom et al., Defining the Role of Cognitive Behavioral Therapy in Treating Chronic Low Back Pain:
An Overview 5 GLOB. SPINE J. 496, 496 (2015).
41
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CBT helps patients recognize the role that negative emotions and cognition play in influencing
pain perception and recategorize pain by viewing it as a brain state, whereby the patient sees herself
or himself as a well person who has pain.47 CBT decreases the individual’s obsession with pain,
his or her constant urge for medical help, and, thereby, assists patients in managing their diseases.48
Studies show that CBT improves chronic pain.49 One study compared patients with chronic
pain to a healthy control group.50 The results established that, “[a]fter 11 weeks of CBT, patients
with chronic pain had gray-matter volumes in the bilateral dorsolateral prefrontal, posterior
parietal, anterior cingulate, and orbitofrontal and sensorimotor cortices similar to those found in a
healthy control group.”51 This study showed tremendous implications for the impact of CBT on
chronic pain, particularly through the evidence that neural pathways modified by pain can be
uncoupled when pain begins to subside and patients begin to conceptualize pain differently.52
A 2012 Cochrane Database Systemic Review found that CBT had “small to moderate
positive effects on pain, disability, and mood immediately after treatment compared with treatment
as usual.”53 Other reviews of CBT supported that finding, demonstrating that the treatment helps
with both pain and depression.54 A randomized clinical trial found that patients who participated

47

Id. at 497.
Murphy, supra note 24, at 26.
49
Id. at 10.
50
David A. Seminowicz et al., Cognitive behavioral therapy increases prefrontal cortex gray matter in patients with
chronic pain, 14 J. PAIN 1, 5 (2013),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874446/pdf/nihms532417.pdf.
51
Id. at 2.
52
Id. at 6.
53
Amanda Williams et al., Psychological therapies for the management of chronic pain (excluding headache) in
adults, 11 COCHRANE DATABASE SYSTEMATIC REVIEW 1, 2 (2012),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483325/pdf/CD007407.pdf.
54
Dawn M. Ehde et al., Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and
directions for research, 69 AM. PSYCHOLOGIST 153, 159 (2014).
48
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in CBT or other mindfulness-based therapy had better outcomes after 26 weeks than those who
did not receive these treatments.55 A study conducted by a team at Group Health Research Institute
in Seattle compared different chronic low back pain treatment methods and concluded that 8 weeks
of CBT can improve back pain over 6 months.56 Thus, research suggests that CBT can improve
outcomes in patients with chronic pain.
2. How Physical therapy can effectively alleviate chronic pain
Physical therapy (“PT”) utilizes exercises and physical manipulation to preserve, restore,
and improve range of motion and physical function after impairment caused by an injury, disease,
or disability.57 Physical therapy has benefits for certain types of chronic pain patients, including
some who take prescription opioids.58 However, insurance companies routinely place limitations
on the number of PT visits and reimbursement, and this interferes with treatment efficacy.59
Physical therapy is an integral component of chronic pain treatment; it helps improve
physical functionality and quality of life by enhancing a patient’s ability to engage in various

55

Daniel C. Cherkin et al., Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care
on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial, 315 THE J.
OF THE AM. MED. ASS’N 1, 8 (2016), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914381/pdf/nihms781082.pdf.
56
Harrison Wein, Meditation and cognitive-behavioral therapy ease low back pain, NATIONAL INSTITUTES OF HEALTH
(Mar. 29, 2016), https://www.nih.gov/news-events/nih-research-matters/meditation-cognitive-behavioral-therapyease-low-back-pain (citing Daniel C. Cherkin et al., supra note 54, at 8 (2016)).
57
Physical Therapy Definition, Merriam-Webster Dictionary, available at https://www.merriamwebster.com/dictionary/physical%20therapy.
58
Per the CDC press release following misapplication of the guidelines, these evidence-based alternatives are not
appropriate as the front-line approach for conditions like oncology and terminal illnesses. See Press Release,
Centers for Disease Control and Prevention, CDC Advises Against Misapplication of the Guideline for Prescribing
Opioids for Chronic Pain (Apr. 24, 2019), https://www.cdc.gov/media/releases/2019/s0424-advises-misapplicationguideline-prescribing-opioids.html [hereinafter CDC PRESS RELEASE].
59
Erik Carvalho et al., Insurance Coverage, Costs, and Barriers to Care for Outpatient Musculoskeletal Therapy and
Rehabilitation Services, 78 N.C. MED. J. 1, 1 (2018).
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activities.60 A JAMA Network Open study observed patients experiencing pain in four categories
(back, knee, neck, or shoulder pain).61 This study analyzed outcomes of 88,985 patients with
private insurance who either received PT within 90 days of their initial doctor visit or did not
receive such PT treatment.62 The data, collected at 91 and 365 days, found that a visit to a physical
therapist early on can eliminate patients’ need for opioids and reduce the number of pills for those
who do need to take prescription opioids for all 4 conditions assessed.63 Thus, the benefits of
physical therapy for chronic pain are clear and widely recognized.
3. Acupuncture as an efficacious treatment for chronic pain
Acupuncture helps chronic pain more than traditional treatment methods, according to
studies.64 Acupuncture involves stimulating specific points on the body by techniques, including
insertion of thin metal needles through the skin.65 Ten million acupuncture treatments are
administered in the United States annually.66 Three million American adults receive acupuncture
each year; chronic pain is the leading reason for treatment.67 Acupuncture’s analgesic effect can
happen almost immediately for pain patients, but the mechanism for how it works is unclear.68

60

Eric Sun et al., Association of Early Physical Therapy With Long-term Opioid Use Among Opioid-Naive Patients
With Musculoskeletal Pain, 1 THE J. OF THE AM. MED. ASS’N NETWORK OPEN 1, 7 (2018).
61
Id. at 1.
62
Id. at 3.
63
Id. at 6.
64
Dionysios Trigkilidas, Acupuncture therapy for chronic lower back pain: a systematic review, 29 ANNALS OF THE
ROYAL C. OF SURGEONS OF ENGLAND, 595, 596 (2010).
65
Mayo Clinic, ACUPUNCTURE, https://www.mayoclinic.org/tests-procedures/acupuncture/about/pac-20392763 (last
visited Nov. 21, 2019).
66
Jason Jishun Hao & Michele Mittelman, Acupuncture: Past, Present, and Future, 3 GLOB. ADVANCES IN HEALTH
AND MED. 6, 6 (2014).
67
Andrew J. Vickers et al., Acupuncture for chronic pain: individual patient data meta-analysis, 172 ARCHIVES OF
INTERNAL MED. 1444, 1444 (2012).
68
Kenji Kawakita & Kaoru Okada, Acupuncture therapy: mechanism of action, efficacy, and safety: a potential
intervention for psychogenic disorders?, 8 BIOPSYCHOSOCIAL MED. 1, 2 (2014).
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In a systematic review with meta-analysis, acupuncture was associated with greater,
immediate relief of chronic pain compared to sham acupuncture or analgesic injection.69 In a metaanalysis on the long-term impact of acupuncture, 90% of acupuncture benefits persisted 12-months
after the conclusion of the course of treatment.70 Another study conducted by researchers from the
University of York and Hull York Medical found that acupuncture impacts particular neural
structures.71 Their research showed that acupuncture “deactivates” brain areas associated with
processing pain.72 The many studies and reviews show that acupuncture reduces chronic pain.
B. How efficacy of evidence-based alternatives has led to changes in guidelines
and the clinical framework
1. CDC Guidelines and their recommendation of using non-opioids to
treat chronic pain
The efficacy of non-pharmacological evidence-based alternatives in comparison with
opioids has resulted in changes to guidelines for clinicians.73 The Centers for Disease Control and
Prevention (“CDC”) released guidelines that recommend non-drug approaches as the preferred
treatment methods for chronic pain and use of non-opioids over opioids.74 Opioids should only be
used (i) in combination with non-pharmacological evidence-based alternatives, and (ii) if the
“expected benefits for both pain and function are anticipated to outweigh risks to the patient.”75

69

Anfeng Xiang et al., The Immediate Analgesic Effect of Acupuncture for Pain: A Systematic Review and MetaAnalysis, 2017 EVIDENCE-BASED COMPLEMENTARY & ALTERNATIVE MED. 1, 4 (2017).
70
Hugh MacPherson & Emily A. Vertosick, The persistence of the effects of acupuncture after a course of treatment:
a
meta-analysis
of
patients
with
chronic
pain,
158
PAIN
1,
11
(2017),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393924/.
71
Aziz Asghar et al., Acupuncture needling sensation: the neural correlates of deqi using fMRI, 1315 BRAIN
RESEARCH 111, 111 (2010).
72
Id. at 111.
73
Dowell et al., supra note 15, at 11.
74
Centers for Disease Control and Prevention, GUIDELINES FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN,
https://www.cdc.gov/drugoverdose/pdf/guidelines_factsheet-providers-a.pdf (last visited Nov. 21, 2019).
75
Id. at 1.
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The CDC explicitly notes that different evidence-based alternative treatments improve
functionality, and the benefits last from 2 weeks to 6 months.76 Due to controversy surrounding
physician practices attributed to the guidelines that were inconsistent with its recommendations,
the CDC released commentary highlighting that the guidelines are not a one-size-fits-all approach
and, thus, not appropriate for patients with conditions where opioids are medically necessary, such
as active cancer, sickle cell disease, and post-surgical pain.77 The commentary also warned
prescribers about the dangers of tapering patients off opioids too abruptly and applying the dosage
guidelines improperly.78 The guidelines recommend integrating non-pharmacological evidencebased alternatives,79 but do not require such treatment for any particular length of time.
2. The Pain Management Best Practices Inter-Agency Task Force Report
and its findings on gaps and recommendations
As a result of 2016 federal legislation enacted in response to the opioid crisis,
representatives from the Departments of Health and Human Services, Veterans Affairs, and the
Department of Defense joined forces to create the Pain Management Best Practices Inter-Agency
Task Force (“Pain Management Task Force”).80 The Pain Management Task Force released a
report with recommendations and guidelines for treatment of chronic pain on May 9, 2019.81 The
report emphasizes the critical role of alternative treatment methodologies for chronic pain and

76

Dowell et al., supra note 15, at 7.
Id. at 29.
78
Id. at 13.
79
Id. at 11.
80
Comprehensive Addiction and Recovery Act of 2016, Pub. L. No. §114-198, 130 Stat. 695.
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recommended physical therapy and occupational therapy, among others.82 The Task Force also
identified barriers to access to care, lack of understanding of these alternative therapies for pain by
both patients and clinicians, and recommended investments in research to help providers
incorporate these therapies into multidisciplinary treatment plans.83 The report further focused on
reimbursement, recommending that Medicare, Medicaid, and private payers “develop appropriate
reimbursement policies; . . . minimize insurance coverage delays; restore reimbursement to
nonhospital sites of service to improve access; and, lower the cost of interventional procedures.”84
Agencies and Congress started to look at the Task Force’s report and recommendations.85
As the next section of this paper describes the funding that will help create change, it is important
to remember that one element—a mandatory component implementing evidence-based treatment
methods for chronic pain—is still missing.
3. National Institutes of Health funding initiatives as a step toward change
On September 26, 2019, the National Institutes of Health (“NIH”) awarded $945 million
in funding across 41 states to support efforts to treat chronic pain through non-addictive methods,
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prevent opioid misuse and overdose, and improve recovery from opioid addiction, among other
components.86 As the HHS Secretary pointed out, “This historic investment by NIH was made
possible by funding secured from Congress by President Trump and will support [the future ability
to] ‘manage pain in an effective, personalized way.’”87 This initiative is called the Helping to End
Addiction Long-Term Initiative (“NIH HEAL Initiative”).88 As part of the program, people
suffering from chronic back pain will participate in a study on the effects of acupuncture on chronic
back pain, and Medicare will cover the treatments for participants.89
Francis S. Collins, M.D., Ph.D., the NIH director who created the initiative stated,
It’s clear that a multi-pronged scientific approach is needed . . . and [t]his unprecedented
investment in the NIH HEAL Initiative demonstrates the commitment to [reduce the risks
of opioids, accelerate development of effective non-opioid therapies for pain and provide
more flexible and effective options for treating addiction to opioids,] reversing this
devastating crisis. 90
“By the end of 2019, HHS will have awarded more than $9 billion in grants to states and local
communities to help increase access to treatment and prevention services since the start of the
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Trump administration.”91 This is a significant improvement in funding for chronic pain.92 Efforts
are underway to improve the treatment of chronic pain.
C. The necessity of individualized, patient-centered multidisciplinary
treatment plans
Evidence-based therapies work well alone or as part of a multimodal treatment plan for
chronic pain.93 These non-opioid therapies are safe and effective ways to reduce the need for
opioids.94 Evidence-based alternative treatment methods are low risk, low cost, and accepted by
patients, as discussed below.95 Many alternative treatments have been used successfully for
thousands of years.96 Importantly, one modality may work for one pain condition but not others.97
There is significant support for the notion that evidence-based alternative are lower risk
than opioid therapies.98 The side effects are not potential drug dependency as with opioids, but
instead have a reverse effect, helping to eliminate the need for opioids and reduce the dosage
prescribed.99 Lower opioid use decreases both pharmacological side effects and the potential for
addiction and abuse.100 For example, the NIH, as an agency deeply invested in human health
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outcomes, released the “NIH Consensus Statement on Acupuncture . . . in 1998[, stating,] ‘the
incidence of adverse effects [from acupuncture] is substantially lower than that of many drugs or
other accepted procedures for the same conditions.’”101
In terms of cost-effectiveness, several economic analyses compared the costs and health
effects between two or more pain therapies and showed more benefit for the economic investment
in non-pharmacological evidence-based alternatives than opioids.102 For example, a review of
cost-effectiveness of non-pharmacological alternatives for treating low back pain demonstrated
that acupuncture was a cost-effective option; the paper reasoned that although individual
acupuncture sessions costed more per session, the pain management benefits lasted for a longer
duration than the three-month study, which overall led to a decrease in spending on treatment.103
Although a study on the barriers to increased uptake of non-pharmacological treatment
modalities pointed out a belief among patients that nonpharmacologic therapies are an additional
expense104, an analysis of the scope of economic benefits changes this perception.105 Costs savings
from use of evidence-based alternatives include outcomes such as “the avoidance of high tech
conventional care, lower future healthcare utilization, and reduction of productive loss for
employers.”106 The State of Washington performed a study that reported that insurance
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expenditures only modestly increased even when a significant number of insureds received nonpharmacological therapies.107 This finding led to a follow-up study of state-insured patients with
back pain, fibromyalgia and menopause symptoms, which showed lower overall insurance costs
for people who used evidence-based alternatives versus those who did not.108
A different study that looked at costs in an interdisciplinary pediatric pain clinic using
acupuncture, biofeedback, psychotherapy and massage with medication showed decreased
inpatient and emergency department visits.109 This resulted in an outstanding cost savings of
$36,228 per patient per year in hospital costs and $11,482 per patient per year in insurance costs.110
These cost analyses support the integration of an individualized interdisciplinary pain plan. It also
shows how accessibility to and participation in a pain clinic over one year can significantly reduce
economic costs by more than the cost of the intervention itself.111
Patients accept non-pharmacological alternatives. A review that looked at education on
and accessibility to non-pharmacological alternatives showed that seventy-five percent (75%) of
patients who previously did not use evidence-based alternatives would utilize these treatments
after gaining awareness of and accessibility to such therapies.112 This statistic came from a study
of 103 Veterans in a Midwestern VA Medical Center that assessed whether Veterans would report
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an increase in evidence-based alternative utilization after completing a formal pain education
program.113 The educational course took place 1-day-per-week for 12-weeks and introduced the
Veterans and their families to twenty-three (23) different nonpharmacologic therapies for pain.114
The results of the study demonstrated a significant increase in the overall utilization of evidencebased alternatives by the Veterans after the education program.115
Patients have better outcomes when they play an active role in their improvement.116 A
study supported the literature suggesting that “when patients are partners in their own care, they
have better outcomes and medication costs decrease.”117 When people reap the benefits of nonpharmacological alternatives, they feel better, and they actively choose to practice them on their
own.118 Resultantly, patients experience pain relief benefits that result in lower utilization of
pharmacological medication.119 Importantly, and as suggested by the CDC’s 2016 prescribing
guidelines commentary, clinicians need to weigh both the pros and cons of non-pharmacological
alternatives based on the individual patient’s pain and gear the treatment plan toward the patient’s
needs and goals.120 Although chronic pain patients organized over the last few years, claiming
that opioids are the best treatment modality for chronic pain and that they should not be tapered
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off of prescription opioids, arguably, they vocalized their views because health care practitioners
ignored their needs. Practitioners did not utilize the CDC guidelines properly, and patients did not
have ready access to non-opioid treatment methods.121 Resultantly, these patients sought relief.122
A multidisciplinary approach is critical. A study on the efficacy of a multidisciplinary
approach for treating chronic pain assessed the effects of a 15-week multidisciplinary treatment
program for pain rehabilitation, specifically focusing on pain and the ability to function and
perform activities.123 The program consisted of CBT and exercise, along with individual and group
sessions that incorporated other treatment modalities.124 The program rated participants’ pain and
assessed the patients’ pain over time.125 This 165 patient study showed statistically significant
improvements for the subjects between admission and discharge.126 The study reinforces the theory
that non-pharmacological alternatives work for chronic pain, and a multimodal approach is
effective.127 A multidisciplinary, individualized approach to pain management is essential.
D. Disparities due to non-existent overarching pain management framework
and lack of insurance coverage
1. Problems with a non-universal framework and gaps in coverage
Current law lacks an overarching framework for insurance coverage of pain management
techniques. With the exception of a few individual states that pushed for the implementation of
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specific evidence-based alternatives through now enacted or pending bills (Georgia,
Massachusetts, New York, and Rhode Island cover or may in the future cover chiropractic care,
for example), steps taken did not resolve the larger problems with the approach to coverage for
pain management.128

The current administration and federal agencies started dedicating

significant funding toward pain management through its initiative to stop the opioid crisis, but now
states through their medical boards which are responsible for regulating the practice of medicine,
need to take control and handle pain management.129
Hospitals, including VA medical centers, pushed for transparency in opioid
administration.130 While these transparency measures certainly are steps in the right direction, it
does not mean that the law should become so draconian and anti-opioid that people who need
opioids are ultimately denied opioid treatment.131 Without a national framework, unintended
disparities in access to evidence-based alternatives will inherently exist and persist.
2. The status of insurance coverage: failure to cover and restrictions limiting
accessibility
In reflecting on the American College of Physicians (“ACP”) 2017 guidelines, scientists
assessed the state of insurance coverage for non-pharmacological evidence-based alternatives.132
The ACP guidelines recommended non-pharmacological alternatives for chronic low back pain.133
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The study looked at minimum required coverage and limitations and exclusions.134 In nearly all
state-based coverage policies, chronic pain management and multidisciplinary rehabilitation were
not addressed.135 Coverage was the highest for chiropractic care, in a total of 46 states.136 Less
than ten states covered acupuncture, massage, and biofeedback.137 Insurance did not cover tai chi
or yoga.138 Insurance accepted CBT often as mental health therapy, but excluded it for treating
pain.139

The study shows that health care practitioners and facilities did not optimize the

coordination of non-pharmacological care across disciplines, despite recommendations suggesting
incorporation of non-pharmacologic alternatives.140 Insurance impeded efforts to utilize such
treatment methods due to its restrictions and exclusions, despite the evidence base for these
treatment methods.141
E. Findings from brain imaging related to chronic pain and healing
Brain imaging demonstrates that pain causes neural pathways to rewire in the brain and, as
patients recover from pain, these pathway changes uncouple.142 A study on brain activity in chronic
pain patient groups (chronic back pain, osteoarthritis, chronic pelvic pain, chronic post-herpetic
neuralgia, chronic complex regional pain syndrome)—with either (i) spontaneous pain, (ii) pain
due to a stimulus that does not normally provoke pain, or (iii) acute thermal mechanical stimuli—
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found that each chronic pain condition evoked a brain activity pattern unique to the condition.143
The study showed the presence of ongoing pain in different brain regions than acute pain,
specifically regions more related to emotions and self-evaluation.144
Tools to show the physical correlates of pain include EEG, MRI, and X-ray, for example.145
As for pain diagnosis, there is no way to map how much pain a person is experiencing; there is no
test to measure pain intensity, and no instrument can locate pain precisely.146 Chronic pain can
cause a reduction in the brain’s gray-matter volume, presumably due to the effects of chronic
stress.147 Neuroimaging studies demonstrated the reversal of such anatomical changes in the brain
when effective CBT was part of the treatment regimen for chronic pain.148
A forthcoming study focused on “overcoming chronic pain” involves a researcher’s use of
a brain imaging study to determine the efficacy of a new mindbody approach for the treatment of
chronic back pain.149 The study—performed at the University of Colorado Boulder between July
and September 2019—involved 90 chronic back pain patients: “30 patients [were] treated with a
mindbody approach, 30 patients . . . receive[d] a placebo injection, and another 30 patients . . .
receive[d] no treatment at all.”150 All 90 patients underwent fMRI brain scans both before and after
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treatment to objectively assess the changes in pain for members of each group.151 The results have
not been published yet. This study shows that society is, contrary to the Carradine case mentioned
earlier, recognizing that some forms of chronic pain are not caused by physical problems in the
body, but rather through modified neural pathways in the brain.152 Just as the body learns pain and
the brain forms new synaptic profiles, when pain relief and renormalization of cognitive abilities
occur, gray matter can increase and the disease can reverse.153
III.

SOLUTION—LEGAL REFORM: BRIDGING THE GAP THROUGH A
MANDATORY EVIDENCE-BASED TREATMENT PLAN IN PLACE OF
OPIOIDS (OR IN CONJUNCTION WITH OPIOIDS WHERE MEDICALLY
NECESSARY)
A. Provision of chronic pain-related HHS funding to state medical boards
contingent upon implementation of evidence-based alternative treatment
plans
There are gaps in the protocol for treating chronic pain, and the law needs to make access

to alternatives a priority. The proposed course of action is implementation of a mandatory
evidence-based treatment plan in place of opioid therapy or, where medically necessary, in
conjunction with prescription opioids. HHS should mandate alternative treatment as a component
of chronic pain management. In order to avoid Tenth Amendment issues and running afoul of the
Constitutional delegation of the right to regulate the practice of medicine to the states, HHS should
condition future chronic pain funding to the states in connection with the initiative to stop the
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opioid crisis, on each state’s compliance with an mandatory evidence-based treatment plan
program.154 Under the U.S. Constitution,
[A]lthough the states have ceded the power to regulate interstate commerce to the federal
government, they retained, via their police powers, the right to regulate any activity that
poses a threat to the public health or safety of their citizens. Thus, state laws that seek to
ban the import of milk from outside the state to protect local dairies are an unconstitutional
attempt to control trade. In contrast, state laws that focus on consumer protection, such as
requiring the sanitary inspection of imported milk and banning the import of contaminated
milk, are constitutional, provided they also apply to milk produced within the state. This
distinction between laws affecting commerce and laws affecting health and safety is
important to medical care practitioners because the regulation of the practice of medicine
is considered a health and safety issue and thus reserved to the states as a police power.155
HHS contingent funding and resources should make an impact immediately to effectuate the
required multidisciplinary non-pharmacological treatment plan for patients with chronic pain
discussed in this paper. As part of this initiative, the state medical boards should require doctors
to develop compliant treatment plans, and when practitioners are compliant, the state medical
board becomes eligible for the funding from HHS.
The protocol that practitioners need to implement for their states to be eligible for HHS
funding must ensure that the patient treatment plan is individualized, specific to each patient’s
needs and goals, and integrates some combination of non-pharmacological, evidence-based
treatment alternatives, such as cognitive behavioral therapy, acupuncture, or physical therapy. A
patient’s plan could incorporate telehealth and telemedicine if mobility is an impediment to

See U.S. CONST. amend. X (reserving “the powers not delegated to the United States by the Constitution, nor
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attending treatment sessions. The protocol also should mandate a 15-week treatment plan for
patients that incorporates the treatment methodologies the patient needs to realize positive changes
in health outcomes. The patients who need opioids visit their health care providers regularly to
discuss their status regardless, in order to receive new prescriptions. Those visits should include
provider inquiries about patient attendance at their mandated treatment plan sessions where
providers evaluate the individual’s plan and make adjustments as necessary.
B. Required Insurance Coverage
Additionally, HHS should ramp up Medicare and Medicaid reimbursement for alternative
pain therapies. Insurance companies need to cover these alternatives. Analogous to the withholding
of funding in South Dakota v. Dole, it is up to the states to follow the protocol here.156 If a state
elects to participate in this program, that state will receive enhanced reimbursement for providing
evidence-based alternatives, and as a condition of receiving the bolstered reimbursement funding,
the state will need to comply with HHS’s rules for the program. Since the Center for Medicare and
Medicaid Services (CMS) falls under the operating divisions of HHS, HHS and CMS should work
together on this effort.157 HHS would then provide reimbursement.158
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HHS’s Pain Management Best Practices Inter-Agency Task Force, in its Task Force
Report, made some relevant recommendations related to this paper.159

The Task Force

recommended that CMS and private payers implement improved payment models that cover
integrated, multidisciplinary pain management, including CBT.160 This model indicated that CMS
and private payers should specifically provide reimbursement for pain management consistent with
the time and resources dedicated to educating and evaluating the patient (including risk for
misuse), re-evaluating the patient after initiating treatment, and integrating evidence-based nonpharmacological alternatives to opioid therapy.161 CMS and private payers should also align their
reimbursement guidelines for chronic multidisciplinary pain management with current clinical
practice guidelines.162

Additionally, payers need to provide reimbursement for non-opioid

pharmacologic therapies that are more expensive than opioids, such as long-acting local anesthetic
injections and infusions and intravenous acetaminophen analgesia, because as discussed
previously, there are longer-term economic benefits of providing this coverage.163

With a

contingent funding mechanism, CMS and private payers will cover evidence-based alternatives.
C. The Pain Management Team Model
Crucial to the success of this proposal, the individualized, multidisciplinary treatment plans
for chronic pain management require organization through a team of specialists.164 This is a best
practice, yet the current reimbursement models are barriers to providing this type of treatment.165
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Payers should follow a chronic disease management model for reimbursement and should include
reimbursement for multidisciplinary pain care similar to that used for cardiac rehabilitation and
diabetes programs.166 In addition, the reimbursement should cover the time teams spend
coordinating patient care.167 The Task Force also recommends development of a CPT code for
pain care coordination and conferences.168 There should be a telehealth option for reimbursing
pain management to facilitate access in underserved locations that payers cover as well.169
The law should necessitate that insurance companies cover all of the evidence-based
alternatives that the doctor recommends for the patient, as mentioned above. Additionally, as part
of the program, patients with chronic pain could use an identification card that allows them to
attend unlimited sessions of group evidence-based alternative treatment sessions to supplement the
mandated plan that the patient follows. HHS should post the locations that offer group medical
treatments for chronic pain and make the services free to participants, as long as they sign up in
advance—by phone or through the website—so the health care provider location can have the
appropriate medical staff on site to provide the service. HHS, through the states, should provide
these service providers with a stipend for the cost of having the necessary medically trained
personnel conduct the sessions. HHS, as part of its contingent funding program, can withhold this
funding unless states make the evidence-based alternative treatment plans mandatory.
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D. Reasoning for 15-Week Program Length
This paper derived the calculation of a 15-week mandated program based on the results of
the studies discussed earlier in this paper. The 15-week program mentioned previously showed
statistically significant changes in patient outcomes attributable to their multidisciplinary treatment
plan.170 A CBT study showed that after 11 weeks of CBT, patients with chronic pain had healthier
gray-matter volumes in their brains.171 The physical therapy study showed improvements over 5
to 8 sessions.172 The acupuncture study showed changes in patients over 12 weeks.173 Fifteen
weeks seems like a prudent determination of a meaningful duration to start to create improved
health outcomes for patients with chronic pain. The plan should allow for extension as needed,
depending on the patient’s results and need for more therapy.
This proposal, while unique insofar as it is mandatory, is not novel in its elements or
approach. A Position Statement from the American Academy of Pain Medicine, which discussed
Minimum Insurance Benefits for Patients with Chronic Pain, proposed a framework on March 7,
2014 with regard to insurance coverage.174 The proposal targeted the treatment of pain that is not
expected to resolve in the near future and that is not responsive to other treatments.175 The coverage
framework

included

(i)

Medical

management;

(ii)

Evidence-

or

consensus-based

interventional/procedural therapies; (iii) Ongoing behavioral/psychological/psychiatric therapies;
(iv) Interdisciplinary care; and (v) Evidence-based complementary and integrative medicine (e.g.,
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yoga, massage therapy, acupuncture, manipulation).176 The American Academy of Pain Medicine
suggested comparable coverage to the level of treatment coverage for people with mental-health
disorders, and, similar to this paper, argued that limited visits and other restrictions including
limited reimbursement are not appropriate for patients with unremitting pain.177 The proposed
mandated program of a 15-week multidisciplinary treatment plan for chronic pain patients will
benefit people suffering from the disease of chronic pain.
IV.

ADDRESSING THE RESISTANCE TO CHANGE
Doctors and patients voiced concerns about the “cost” of chronic pain management, and

this section addresses those concerns. The arguments include higher costs and impracticability of
spending time on alternatives, as well as requiring insurance companies to cover unprecedented
treatment options.178 The media, some studies, and other publications echoed these concerns.179
In a study that interviewed primary care providers regarding treating co-morbid chronic
pain and opioid use disorder, the doctors reported that barriers to implementing alternatives include
lack of resources like staff, time, and access to alternatives.180 Regarding the barrier of time, the
PCPs explained that they do not have the time to spend working with patients on alternative
treatment plans.181 A separate study by Lauren S. Penney and her team on provider and patient
perspectives regarding alternatives to opioids for managing chronic pain, quotes a primary care
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physician, who sheds light on this perspective, “We get our little ten-minute[s] per patient, which
is so grossly, woefully an inadequate amount of time to see a patient. Ten minutes, right, for all
your problems. And so nobody wants to take the time to explore things other than drugs for people
with chronic pain.”182 This is problematic and is an issue that HHS contingent funding can address,
especially if it compensates health care providers for the time spent implementing nonpharmacological alternatives and coordinating care among various service providers.
The aforementioned study from 2007, which discussed efficacy of alternative pain
treatments flagged some duplicative issues and some different concerns relevant to the difficulties
for practitioners making decisions about using or incorporating alternatives, including the
following:
additional time and energy investments, the need for specially trained personnel to
administer the modalities, known or potential side effects, safety in combining alternatives
and other modalities, likely acceptance by clients and the public (and hence the issue of
long-term adherence), and ease of incorporation into traditional pain management
practices.183
Another argument against the implementation of the proposed multidisciplinary, individualized
evidence-based alternative plans for chronic pain patients is the contention that insurance
companies will need to expend (potentially substantial) money on alternative treatments that they
have failed to previously cover.184
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These critiques beg the question: How can we assess whether these concerns are legitimate
if we have never truly attempted to incorporate these alternatives? This paper argues that quick
fixes with opioids alone have failed to solve problems for people with chronic pain, and the need
for integration of non-pharmacological, evidence-based alternatives is critical to helping these
patients. Chronic pain costs our country because people are suffering and dying from misuse of
opioids.185 The cost of alternative treatments cannot truly be assessed without attempting to
effectively implement a program to fill the known gaps in chronic pain treatment.
To put this in perspective, Professor Jennifer Oliva, who specializes in health law and is
following the opioid crisis closely, pointed out that monetarily, “the cost of the opioid crisis
exceeds $1 trillion dollars and is rising every day already.”186 These extravagant costs demand a
new approach to try to fix this problem. Professor Oliva also pointed out that “by certain
projections, the crisis will continue to get worse before it gets better, meaning that it is critical to
implement evidence-based alternatives as soon as possible.”187
Chronic pain costs the United States $560 to $635 billion annually, according to the
National Academy of Medicine.188 This cost is higher than the nation’s annual expenditures for
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heart disease, cancer, and diabetes combined.189 “We can expect the chronic pain burden to
escalate,”190 especially as chronic illnesses increase over time.
This paper takes the position that “most of the nonpharmacologic strategies are
underutilized due to lack of evidence dissemination, education, and reimbursement. It is time for
civilian medicine to join the call to action of military medicine outlined by Schoomaker and
Buckenmaier.191 They urge the immediate incorporation of nonpharmacological evidence-based
alternatives and active self-care, due to their safety, efficacy, and acceptance by patients.192 Their
call to action aims to increase awareness, access, and utilization of nonpharmacologic treatments
through education of practitioners and patients; to disseminate and reimburse evidence-based
treatment options; and to promote ongoing research focused on the therapeutic and economic
impact, in the short and long term, of comprehensive care practices.193 Importantly,
[t]here is an additional benefit to many nonpharmacological pain care strategies; unlike
drugs and surgery, the [evidence-based alternatives] involve patient participation and a
commitment to self-care. Increased self-efficacy in managing pain correlates with
improved mood and predicts improved outcomes in many chronic conditions, including
pain. For example, the military has studied ‘active self-care therapies’ as a category of
pain management that may be of value in an integrated, multimodal approach.194
Patients can perform many of these therapies on their own, reaping the ongoing benefits, cost free,
as they apply the therapies and techniques in their everyday lives.195 An individual can practice
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the CBT coping skills on their own and perform exercises on their own, for example, causing
accelerated healing rates because of the added benefits achieved between sessions.196
Medicine and policy decision-making professionals acknowledge the crisis in pain and pain
care.197 “If we could find a way of intervening, . . . then the . . . need [for] opioids or heavy doses
of analgesics will diminish.”198 Through an effective legislative framework, a solution can be
found. As mentioned earlier and worth repeating, “[i]nstead of symptom management, we would
be managing the disease.”199
CONCLUSION
People suffering from the disease of chronic pain need a mandatory program that
incorporates evidence-based alternatives in place of, or if medically necessary, in conjunction with,
the prescribing of opioids. Since states are responsible for regulating the practice of medicine,
HHS should condition state funding for chronic pain, provided in connection with the funding for
the opioid crisis, on each state’s implementation of mandatory alternative treatment programs.
HHS should similarly set up a program for supplemental insurance reimbursement for provision
of these evidence-based alternatives. This contingent funding will boost integration of effective
pain management techniques, help mitigate the deadly and costly opioid epidemic, and create
longer sustaining benefits for chronic pain management.
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